Инъекция сукцината этилметилгидроксипиридина

What is Ethylmethylhydroxypyridine Succinate Injection?
Ethylmethylhydroxypyridine Succinate Injection is a neuroprotective and antioxidant drug widely used in the management of neurological and vascular disorders. It belongs to the class of antioxidant agents that protect brain cells against oxidative stress and improve metabolism. The injection is used in stroke therapy, brain injury, and cardiovascular conditions, helping to restore normal blood flow and cognitive function.
 
Uses of Ethylmethylhydroxypyridine Succinate Injection
Treatment of acute ischemic stroke
Management of traumatic brain injury and neurotrauma
Cognitive disorders and memory impairment
Adjunct therapy in cardiovascular ischemia
Management of anxiety and stress-related conditions
 
How Does Ethylmethylhydroxypyridine Succinate Injection Work?
The drug acts as a powerful antioxidant, inhibiting free radical activity and lipid peroxidation in cell membranes. It improves oxygen utilization in tissues, enhances neuronal metabolism, and stabilizes cell membranes. This results in improved cerebral blood flow, neuroprotection, and faster recovery in stroke and trauma patients.
 
Frequently Asked Questions (FAQs)
Q: What is Ethylmethylhydroxypyridine Succinate Injection used for?
A: Ethylmethylhydroxypyridine Succinate Injection (also known as Emoxypine) is a neuroprotective and antioxidant agent. It is primarily used to treat acute ischemic stroke, traumatic brain injury (TBI), and cognitive impairment. It protects brain cells from oxidative stress and improves cerebral blood flow, aiding recovery in neurological and vascular disorders.
Q: Who is a top manufacturer of Ethylmethylhydroxypyridine Succinate Injection in India?
A: Farbe Firma Pvt. Ltd. is a leading manufacturer and supplier of Ethylmethylhydroxypyridine Succinate Injection (Trade Name: Ethysyl). We manufacture this specialized cerebroprotective drug in our WHO-GMP certified facility, ensuring high stability and efficacy for markets in CIS countries, Latin America, and Asia.
Q: In what strengths and packing is Ethysyl available?
A: We manufacture Ethylmethylhydroxypyridine Succinate Injection in the standard strength of 50 mg/ml. It is available in 5 ml (250 mg) ampoules, which is the standard dosage form for intravenous or intramuscular administration.
Q: How does Ethylmethylhydroxypyridine Succinate work?
A: It acts as a membrane stabilizer and free radical scavenger. By inhibiting lipid peroxidation and increasing the activity of antioxidant enzymes, it improves the brain's resistance to hypoxia (lack of oxygen) and ischemia, enhancing metabolic processes in neuronal tissues.
Q: Do you offer Contract Manufacturing for this product?
A: Yes, Farbe Firma Pvt. Ltd. offers specialized Contract Manufacturing (CMO) services for Ethylmethylhydroxypyridine Succinate Injection. We provide complete support, including formulation, sterile filling, and regulatory dossier compilation (CTD/ACTD) to help you launch the product under your own brand.
 
Looking for a reliable Ethylmethylhydroxypyridine Succinate Injection manufacturer?
Contact Farbe Firma Pvt. Ltd. for high-quality manufacturing, dossier support, registration assistance, and global export supplies.